Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Malignant Melanoma

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Malignant Melanoma in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prickett, TD1
Gartner, JJ1
Samuels, Y1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Malignant Melanoma

ArticleYear
Genetic and Functional Analysis of GRIN2A in Tumor Samples.
    Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1677

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Cell Movement; High-Throughput Nucleotide

2017